Dare Bioscience (DARE) Acquisitions (2018 - 2019)
Dare Bioscience's (DARE) quarterly Acquisitions came in at $6.1 million in Q4 2019, up 1311.81% YoY from $435177.5 in Q4 2018, and up 1311.81% on a QoQ basis from -$507000.0 in Q4 2018.
Dare Bioscience (DARE) Acquisitions (2018 - 2019) Analysis & Trends
Dare Bioscience (DARE) has 2 years of Acquisitions data on file, last reported at $6.1 million in Q4 2019.
- Quarterly Acquisitions rose 1311.81% year-over-year to $6.1 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $5.7 million (changed N/A YoY) and the FY2019 annual result came in at $6.1 million, changed N/A from the prior year.
- Acquisitions rose to $6.1 million in Q4 2019, from -$507000.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $6.1 million in Q4 2019 to a low of -$507000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Dare Bioscience | 12.51 Mn | -110,135.51 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 6.14 Mn |
| Dec 31, 2018 | -507,000.00 |
| Sep 30, 2018 | 55,000.00 |